Kymera Therapeutics (NASDAQ:KYMR – Get Free Report) posted its quarterly earnings data on Thursday. The company reported ($0.69) EPS for the quarter, topping analysts’ consensus estimates of ($0.73) by $0.04, Briefing.com reports. The firm had revenue of $10.30 million for the quarter, compared to analyst estimates of $14.24 million. Kymera Therapeutics had a negative return […]
Related Keywords
Piper Sandler , Securities Exchange Commission , Wolfe Research , Kymera Therapeutics Company Profile , Venture Fund Xlp Atlas , Jpmorgan Chase Co , Kymera Therapeutics Inc , Kymera Therapeutics , Get Free Report , Director Bruce Booth , Exchange Commission , Venture Fund , Truist Financial , Kymera Therapeutics Daily , Nasdaq Kymr , Kymr , Medical , Earnings ,
comparemela.com © 2020. All Rights Reserved.